Navigation Links
Amylin Pharmaceuticals Reports First Quarter Financial Results
Date:4/16/2009

) was similar to initiators of the more traditional therapies metformin or glyburide.
  • Manuscript in Diabetes Care confirmed a significantly increased risk of pancreatitis in patients with type 2 diabetes - approximately three times the rate of those without diabetes.

  • Exenatide Once Weekly

    • Completed analyses to demonstrate manufacturing comparability necessary for regulatory submission. These analyses will be part of the NDA submitted to FDA this quarter.
    • Announced results from the first head-to-head comparative effectiveness study, DURATION-2, that demonstrated exenatide once weekly provided superior glucose control, with weight loss, compared to maximum doses of Januvia or Actos(R) (pioglitazone).
    • Announced decision to initiate a large cardiovascular outcomes trial with superiority design that will evaluate the effects of exenatide once weekly on major cardiovascular events, compared to standard of care with traditional antidiabetes medications.
    • Initiated DURATION-5, a new phase 3b study designed to show superiority of exenatide once weekly compared to BYETTA, support regulatory submissions outside the U.S. and provide additional controlled clinical data on the commercially manufactured product.

    Conference Call

    Amylin will webcast its Quarterly Update Conference Call today at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. During the call, the Company plans to provide further details underlying its first quarter financial results, and information regarding assumptions for the remainder of 2009 operations.

    The call will be webcast live through the "Investors" section of Amylin's corporate Web site at

    SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine news :

    1. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
    2. Amylin Pharmaceuticals to Webcast First Quarter Results
    3. Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
    4. Amylin Pharmaceuticals Comments on Shareholder 13-D Filing
    5. Amylin Pharmaceuticals Reports 2008 Financial Results
    6. Amylin Pharmaceuticals to Webcast Year-End Results
    7. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
    8. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
    9. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
    10. Lilly and Amylin Set Date and Time for Conference Call
    11. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
    (Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
    (Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
    (Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
    (Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
    Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
    ... developed at Brown University, promises to improve our understanding of ... tomography, or CT, delivers detailed 3-D images, but CT scanners ... that uses X-rays to view objects, can produce moving images ... surgeon trying to figure out the best way to repair ...
    ... All India Institute of Medical Sciences (AIIMS) director P. ... public relation officer filed a police complaint against him. ... relation officer of AIIMS, has filed a police complaint ... accusing Venugopal of harassment, wrongful restraint from entering office, ...
    ... is obviously a difficult question to answer. //There is no ... research that this is a fast growing and potentially widespread ... funded national stem cell depository would allow unfettered access for ... in the future. Unfortunately parents come to us because that ...
    ... want to help smokers kick ‘butts’; keep all warnings// printed ... ,The UN’s World Health Organization (WHO) identifies smoking ... ,It is responsible for the death of one in 10 ... , The researchers led by David Hammond, Ph.D., of ...
    ... campaign pointing out the threat of losing vision due ... young population//. This was cited by the British Journal ... Institute of the Blind, losing vision is considered more ... stroke and lung cancer associated with it. Hence the ...
    ... even today. But whether patients survive cancer seems to depend ... to spend// on the drugs, according to a Canadian report. ... treatment, and some Canadians will live and some will die ... Coalition of Canada report. ,The latest cancer treatments ...
    Cached Medicine News:Health News:AIIMS Official Files Complaint Against Venugopal 2Health News:Statutory Warnings on Cigarette Packs- Make It Bigger and Brighter, Say Researchers 2Health News:Call for a National 'Drugs Funding Program' for Cancer Treatment in Canada 2
    (Date:12/17/2014)... BUENA, N.J. , Dec. 17, 2014  IGI ... announced today the closing of its offering of $125 ... due 2019 (the "Notes").  The Notes were offered and ... 144A under the Securities Act of 1933, as amended ... at a fixed rate of 3.75% per year, payable ...
    (Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
    (Date:12/15/2014)... LONDON , December 15, 2014 /PRNewswire/ ... Am 19. und 20. Februar ... das Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ... zu besuchen. Diese Tagung ... Gemeinschaft die Möglichkeit geben, die neue profitablen ...
    Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
    ... ... a new market research report is available in its ... Market Perspective , http://www.reportlinker.com/p0164258/Cardiac-Biomarkers---A-Global-Market-Perspective.html , ... served as primary growth drivers for cardiac biomarkers market, ...
    ... , ... announces that a new market research report is available ... A Global Market Review , http://www.reportlinker.com/p0164337/Radiation-Therapy-Equipment---A-Global-Market-Review.html ... of new cancer cases diagnosed each year. Radiation therapy ...
    Cached Medicine Technology:Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8
    ... frames are designed with the safety and comfort ... Schott RS-520 (also called SF-6) leaded glass, the ... meet standards, as set for optical clarity, visible ... our eyewear is protecting your eyes, it also ...
    ... Protection Goggles fit over ... used by the whole ... glass, 1.0 mm leaded ... increased scatter radiation protection. ...
    QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
    QualCraft™ Radiation Protection Eyewear providex maximum comfort and eye protection! Lenses made of 0.75 mm leaded glass. Side shields of 0.30 mm leaded acrylic help seal out scatter radiation ...
    Medicine Products: